receive the allocation of the newly issued ordinary shares this time wishing to nominate the company will present the matter to the Board of Directors meeting and / or the shareholders' meeting for further

Limited หน้า 7 จาก 20 Present day, behavior of the consumers are changed so much. They prefer to test the new products and service. They are sensitive with fast sensory and sometime they follow the social

adversely affect the determination of budget allocation for each marketing tools. Moreover, the current economic circumstances have not positively encouraged the operation as anticipated. At present, Blue

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

of short- term borrowings from financial institutions by using money gained from trading of its ordinary shares in the MAI stock exchange. • Other current assets decreased by Baht 19.58 million. This

market share in the economic slowdown. When comparing the sale volume to the same period in 2018, decreased 0.9%. The company is not able to increase the selling price in the current economic conditions

mention previously. Statement of Financial Position Unit: Million Baht) Details 30-Sep-18 30-Sep-17 Increased (Decreased) Percentage Assets Current assets Cash and cash equivalents 14.06 91.98 (77.92

total number of the shareholders present at the meeting and having voting rights, excluding the votes of shareholders having an interest in the matter. The company is required to disclose the information